GeneDx is trading 4.28% higher at $74.00 on October 2, 2026, alongside broader market gains amid weaker-than-expected jobs data and lower rate-hike expectations. - The S&P 500 rose 1.00%, the Nasdaq 1.65%, and the Dow 0.57%. - GeneDx announced Easy Order, a guided portal workflow to simplify pediatricians’ orders for exome testing and chromosomal microarray. - The announcement was not explicitly linked to the share move; no trading-volume details were available.